在原子分辨率下观察到的人类酶在氨基基原性状态下的局部合作性
Anne Dhulesia1, Nunilo Cremades, Janet R Kumita
1Department of Chemistry, University of Cambridge, UK.
Journal of the American Chemical Society
|October 21, 2010
概括
人类酶在低pH下展开,揭示了粉样纤维素形成之前的关键结构变化. 了解系统性粉样性粉症的这些早期事件对于了解疾病机制至关重要.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 分子医学是分子医学.
背景情况:
- 系统性粉症与可溶性蛋白质转化为粉样纤维的发生有关.
- 人类酶的部分展开与一种遗传形式的全身性粉症有关.
研究的目的:
- 描述人类酶的氨基胺原性状态的结构和物理化学特性.
- 通过研究酶展开来阐明系统性粉症的分子起源.
主要方法:
- 差分扫描热度计 (DSC) 用于评估热稳定性.
- 核磁共振 (NMR) 光谱仪用于高分辨率的结构洞察.
- 研究野生型和突变型酶变体的生物物理技术 (I56T,I59T).
主要成果:
- 在低pH的温度下,热解涉及到三级结构的损失,其次是解的状球状状态.
- 展开的温度窗口与变体稳定性和amyloidogenicity相关.
- 酶最初展开的区域与粉样纤维细胞核相对应.
结论:
- 提供了球状蛋白粉样蛋白形成的初始事件的原子分辨率视图.
- 突出了展开路径,蛋白质稳定性和氨基原性之间的联系.
- 提供了对遗传性系统性粉样性粉症的分子基础的见解.
相关概念视频
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Overview

